Cargando…

Dose-dependent effects of small-molecule antagonists on the genomic landscape of androgen receptor binding

BACKGROUND: The androgen receptor plays a critical role throughout the progression of prostate cancer and is an important drug target for this disease. While chromatin immunoprecipitation coupled with massively parallel sequencing (ChIP-Seq) is becoming an essential tool for studying transcription a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Zhou, Shi, Manli, Hu, Wenyue, Estrella, Heather, Engebretsen, Jon, Nichols, Tim, Briere, David, Hosea, Natilie, Los, Gerrit, Rejto, Paul A, Fanjul, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507642/ https://www.ncbi.nlm.nih.gov/pubmed/22849360 http://dx.doi.org/10.1186/1471-2164-13-355

Ejemplares similares

Small Molecule Antagonists of the Nuclear Androgen Receptor for the Treatment of Castration-Resistant Prostate Cancer
por: Johnson, James K., et al.
Publicado: (2016)

Synthesis of Hydantoin Androgen Receptor Antagonists and Study on Their Antagonistic Activity
por: Ma, Longjun, et al.
Publicado: (2022)

Response to Androgens and Androgen Receptor Antagonists in the Presence of Cytokines in Prostate Cancer
por: Culig, Zoran
Publicado: (2021)

CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate Cancer
por: Hwang, Justin H., et al.
Publicado: (2019)

Conformational dynamics of androgen receptors bound to agonists and antagonists
por: Gim, Hyo Jin, et al.
Publicado: (2021)

The Worldwide Landscape of Variants in the Androgen Receptor Gene Related to Androgen Insensitivity Syndrome: An Integrative Analysis
por: Batista, Rafael Loch, et al.
Publicado: (2021)

Similarities and Distinctions in Actions of Surface-Directed and Classic Androgen Receptor Antagonists
por: Suh, Ji Ho, et al.
Publicado: (2015)

Discovery and Identification of Pyrazolopyramidine Analogs as Novel Potent Androgen Receptor Antagonists
por: Wang, Lingyan, et al.
Publicado: (2018)

Development of Androgen-Antagonistic Coumarinamides with a Unique Aromatic Folded Pharmacophore
por: Koga, Hitomi, et al.
Publicado: (2020)

Androgen deprivation therapy and side effects: are GnRH antagonists safer?
por: Freedland, Stephen J, et al.
Publicado: (2020)

Second generation androgen receptor antagonists and challenges in prostate cancer treatment
por: Chen, Yanhua, et al.
Publicado: (2022)

Food components and contaminants as (anti)androgenic molecules
por: Marcoccia, Daniele, et al.
Publicado: (2017)

Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer
por: Kregel, Steven, et al.
Publicado: (2016)

Mechanisms of Androgen Receptor Agonist- and Antagonist-Mediated Cellular Senescence in Prostate Cancer
por: Kokal, Miriam, et al.
Publicado: (2020)

Paradoxical androgen receptor regulation by small molecule enantiomers
por: Patsch, Katherin, et al.
Publicado: (2021)

Small molecule antagonists of melanopsin-mediated phototransduction
por: Jones, Kenneth A., et al.
Publicado: (2013)

A new highly specific and robust yeast androgen bioassay for the detection of agonists and antagonists
por: Bovee, Toine F. H., et al.
Publicado: (2007)

Screening for insulin-independent pathways that modulate glucose homeostasis identifies androgen receptor antagonists
por: Mullapudi, Sri Teja, et al.
Publicado: (2018)

Second-Generation Androgen Receptor Antagonists as Hormonal Therapeutics for Three Forms of Prostate Cancer
por: Rajaram, Pravien, et al.
Publicado: (2020)

Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models
por: Sugawara, Tatsuo, et al.
Publicado: (2019)

Influence of Androgen Receptor Antagonist MDV3100 Therapy on Rats With Benign Prostatic Hyperplasia
por: Yang, Minggen, et al.
Publicado: (2021)

Androgen and retinoic acid interaction in LNCaP cells, effects on cell proliferation and expression of retinoic acid receptors and epidermal growth factor receptor
por: Li, Ming-tang, et al.
Publicado: (2002)

A novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis
por: Bujalska, I J, et al.
Publicado: (2008)

Inhibition of in vivo proliferation of androgen-independent prostate cancers by an antagonist of growth hormone-releasing hormone.
por: Jungwirth, A., et al.
Publicado: (1997)

MDM2 antagonists boost antitumor effect of androgen withdrawal: implications for therapy of prostate cancer
por: Tovar, Christian, et al.
Publicado: (2011)

SAT-722 Structure-Based Discovery of Hydraulic Fracturing Chemicals as Novel Androgen Receptor Antagonists
por: Tachachartvanich, Phum, et al.
Publicado: (2020)

New Antagonists of the Membrane Androgen Receptor OXER1 from the ZINC Natural Product Database
por: Panagiotopoulos, Athanasios A., et al.
Publicado: (2021)

Antagonistic Functions of Androgen Receptor and NF-κB in Prostate Cancer—Experimental and Computational Analyses
por: Basílio, José, et al.
Publicado: (2022)

Cheminformatic Analysis and Machine Learning Modeling to Investigate Androgen Receptor Antagonists to Combat Prostate Cancer
por: Yu, Tianshi, et al.
Publicado: (2023)

In Vitro Androgen Bioassays as a Detection Method for Designer Androgens
por: Cooper, Elliot R., et al.
Publicado: (2013)

Role of maximum androgen blockade in advanced prostate cancer
por: Ayyathurai, Rajinikanth, et al.
Publicado: (2009)

Screen-Printed Electrodes Modified with Metal Nanoparticles for Small Molecule Sensing
por: Antuña-Jiménez, Daniel, et al.
Publicado: (2020)

Human SP-D Acts as an Innate Immune Surveillance Molecule Against Androgen-Responsive and Androgen-Resistant Prostate Cancer Cells
por: Thakur, Gargi, et al.
Publicado: (2019)

The Free Energy Landscape of Small Molecule Unbinding
por: Huang, Danzhi, et al.
Publicado: (2011)

Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation
por: Coleman, Craig I., et al.
Publicado: (2019)

Combined Ligand/Structure-Based Virtual Screening and Molecular Dynamics Simulations of Steroidal Androgen Receptor Antagonists
por: Wang, Yuwei, et al.
Publicado: (2017)

A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients
por: Miyazawa, Yoshiyuki, et al.
Publicado: (2017)

SUN-139 Luminescence-Based Drug Screen for Novel Androgen Receptor Antagonists for Prostate Cancer Therapy
por: Azur, Romie Angelo G, et al.
Publicado: (2020)

Insulin and glucose responses to hypoxia in male and female neonatal rats: Effects of the androgen receptor antagonist flutamide
por: Rolon, Santiago, et al.
Publicado: (2021)

H3K9 methylation drives resistance to androgen receptor–antagonist therapy in prostate cancer
por: Baratchian, Mehdi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0kh3vni2uh034psa4l8cic7dqb